The Hepatitis C market was valued at USD 71.12 Billion in 2024 and is expected to reach USD 197.24 Billion by 2032, growing at a CAGR of 13.6% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.